Press release -

Biolin Scientific acquires the key patent protecting multi-hole, high-throughput ion channel screening

Biolin Scientific today announces the acquisition of a key patent related to performing multi-hole, high-throughput ion channel screening.

“We are pleased to strengthen our position as the leaders in high-throughput ion channel screening and this patent, along with Sophion Qube™, our new instrument platform for high-through put screening, will enable us to screen hundreds of thousands of compounds in our continuing efforts to support and speed up drug discovery”, says Morten Sunesen, VP of Drug Discovery Systems at Biolin Scientific.

The patent describes a method for ensuring high data quality by analyzing multiple cells and thus multiple sets of ion channels under one experimental condition, thus providing extremely high data quality and a truly high throughput screening method.

Biolin Scientific CEO, Johan von Heijne states, “This acquisition underlines our commitment to moving further into high throughput ion channel screening and is an important support and milestone related to the recent launch of the Sophion Qube ion channel screening platform. Additionally, this acquisition affirms our intent to vigorously protect and expand our broad range of intellectual property and to invest in new technologies.”

Topics

  • Chemical industry

Categories

  • patch clamp
  • ion channel screening

Biolin Scientific is a leading Nordic instrumentation company with roots in Sweden, Denmark and Finland. Our customers include companies working with pharmaceuticals, energy, chemicals, and advanced materials, as well as academic and governmental research institutes. Our precision instruments help discover better drugs faster, develop better solutions for energy and materials, and perform research at the frontiers of science and technology.

Biolin Scientific proprietary systems are based on nanotechnology and advanced measurement techniques. They have earned leadership in several industries through our commitment to scientific excellence and continuous product development.

Our commitment to customer service and application support is a key feature of our operations. We focus on working together with customers and building long-standing relations. Today, Biolin Scientific provides products and services in more than 70 countries around the world.

Our portfolio consists of these product brands:
Attension | KSV NIMA | Q-Sense |
Sophion

Contacts

Mattias Bengtsson

Press contact CEO, Biolin Scientific +46 709577337

Related content